Chess did you see the report just posted on wall street cheat sheat. for NWBO It confirms there are patients injected in the new direct trial. I can't tell if your in or out with NWBO. I have traded ADXS since 2008 and know that one fairly well. I personally believe in sticking to NWBO on this boardbut the ADXS board has been off for a while now it is a little odd.
Bob, I had a lot of NWBO and bailed back in May. I still have some but play money. I sold the October calls against this position sold the 5 strike and got .40 cents. Honestly, I don't understand those saying either Powers knows Direct works or will know shortly. First she can't know as of today. The trial was initiated in late June and when I spoke to the company in late Zjuly I was told they were still screening patients. You have to remember, notwithstanding tumor regression as the end point, the need to screen, and then look for adequate dosage. Can dosage also be accompanied by cases with tumor regression? Sure. But you are looking for statistical significance. Given this, I find it hard to imagine a PR from NWBO saying: one of our patients in the phase 1 has had tumor regression. This would be odd not knowing the context I.e., the cancer, the SOC, patients age etc. So I think you need to wait another 2 months for dosage/safety and the accompanying PR then perhaps you have PR of additional sites the cohorts and breakdown of enrolled then I'm thinking February results on efficacy. NWBO will need a capital raise though before end of October. I don't know. The market has assigned 0 probability of success so maybe you buy it here? I simply despise the company, find them inept on so many levels, I question their honesty and integrity and quite frankly think if Powers resigned and whatever mgmt exists were replaced the market cap could double.
You're killing me here... I think everyone knows this is a long shot however, with the PR release today about the patent and clearly stating "it's been used in direct patients" news will be right around the corner.
So will NWBO deliver a very merry chrismas or give investors lumps of coal? We will soon find out.